pr0digal jenius

WILMINGTON, Del.--The judge who will decide whether to block defenses by PeopleSoft against Oracle's $7.7 billion hostile tender offer, ended the two-week trial Friday by urging both sides to agree on what issues remain in contention and leave everything else out of their post-trial briefs.

"It needs to come to a head for all the constituencies concerned," said Vice Chancellor Leo E. Strine Jr. of the Delaware Chancery Court, noting that the parties had moved closer together, leaving only technical and linguistic disagreements.

The judge said he was not in a hurry to get an opinion out, and "wanted to do it in a sensible way."

At issue in the trial are PeopleSoft's poison pill, which would make a hostile takeover prohibitively expensive by nearly doubling the shares to be bought, and a customer rebate that says that if an acquirer of PeopleSoft fails to maintain PeopleSoft software, customers licensed after the tender offer can claim a refund of up to five times their license fee.
_______________
Source/Read more:C|Net